Microvascular Therapeutics Announce Completion of Phase 2 Study Enrollment for MVT-100MVTSep 5, 20242 min read
Microvascular Therapeutics is attending the Contrast Media Research Meeting in Santa Fe this week. Microvascular Therapeutics is attending the Contrast Media Research Meeting in Santa Fe this week. Our CEO, Dr Unger is presenting pre-clinical and clinical results for CardiSon, our next generation o
Microvascular Therapeutics Appoints George Kokke to Board of DirectorsVeteran family office executive and healthcare investor brings more than 30 years of investment, finance, and board experience.
Microvascular Therapeutics Appoints Charles Garrison, MD, to Scientific Advisory BoardExperienced pathologist, biotechnology entrepreneur, and life sciences investor will advise MVT on scientific and medical development